CORGENIX MEDICAL CORP/CO
Healthcare · In Vitro & In Vivo Diagnostic Substances · CO · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|
| Revenue | $11.0M | $10.2M | $9.3M | $7.9M |
| Operating income | $399,601 | $296,385 | −$486,208 | −$135,964 |
| Net income | $371,437 | $278,536 | −$603,702 | −$393,065 |
| Total assets | $7.8M | $6.7M | $6.3M | $7.0M |
| Total liabilities | $1.6M | $1.3M | $1.6M | $2.7M |
| Equity | $6.2M | $5.4M | $4.6M | $4.2M |
| EPS (diluted) | $0.00 | $0.00 | $-0.01 | — |
| Shares out. | 54.2M | 50.5M | 48.0M | 40.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- 3.6%
- Net margin
- 3.4%
- Return on equity
- 6.0%
- Return on assets
- 4.8%
- Return on capital (ROCE)
- 6.0%
- Liabilities / assets
- 20.2%
- Debt / equity
- 0.25×
- Book value / share
- $0.11
- Revenue growth (YoY)
- 8.1%
- Net income growth (YoY)
- 33.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- 2.17grey zone
- Accruals / assets
- −2.5%clean
- Beneish M-Score
- -1.99normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2007
- NT 10-K/Amissed a reporting deadline ↗Sep 24, 2004
- NT 10-Kmissed a reporting deadline ↗Sep 24, 2004
- NT 10-Kmissed a reporting deadline ↗Sep 30, 2003
- NT 10-Kmissed a reporting deadline ↗Sep 29, 2000
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Modified shareholder rights · Change in control · Director / officer change · Other material eventMar 11, 2015
- Other material eventDec 30, 2014
- Shareholder voteDec 18, 2014
- Other material eventNov 19, 2014
- Results of operationsOct 29, 2014
- Other material eventSep 17, 2014
- Other material eventAug 28, 2014
- Entered a material agreementAug 28, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.